CDKN2A and neoplasm: Despite differences in the grading criteria in the literature, our results agree with the report of Ajani et al regarding p16 expression (evaluating the percentage of tumor cells with cytoplasmic staining) in 30 patients with anal cancer treated with CRT [23].